Literature DB >> 2050183

Effect of topical rifamycin SV treatment on cyclosporin A blood levels in a renal transplant recipient.

E Renoult, J Hubert, P Trechot, D Hestin, M Kessler, J L'Hermite.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2050183     DOI： 10.1007/bf00265860

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  7 in total

Review 1.  An appraisal of drug interactions with Sandimmun.

Authors:  I T Cockburn; P Krupp
Journal:  Transplant Proc       Date:  1989-10       Impact factor: 1.066

2.  Interaction between cyclosporin and rifampicin.

Authors:  N J Daniels; J S Dover; R K Schachter
Journal:  Lancet       Date:  1984-09-15       Impact factor: 79.321

3.  Rapid metabolism of cyclosporin and prednisone in kidney transplant patient receiving tuberculostatic treatment.

Authors:  E Langhoff; S Madsen
Journal:  Lancet       Date:  1983-10-29       Impact factor: 79.321

4.  Cyclosporin and rifampicin in renal transplantation.

Authors:  R D Allen; A G Hunnisett; P J Morris
Journal:  Lancet       Date:  1985-04-27       Impact factor: 79.321

5.  Interaction between phenytoin and cyclosporine following organ transplantation.

Authors:  P A Keown; A Laupacis; G Carruthers; M Stawecki; J Koegler; F N McKenzie; W Wall; C R Stiller
Journal:  Transplantation       Date:  1984-09       Impact factor: 4.939

6.  The interaction of rifamycin-SV with the hepatic transport and sulfation of taurolithocolic acid in rats.

Authors:  P Bonazzi; G Novelli; R Galeazzi
Journal:  Pharmacol Res Commun       Date:  1986-08

7.  Correlation of structure and activity in ansamycins. Molecular structure of sodium rifamycin SV.

Authors:  S K Arora
Journal:  Mol Pharmacol       Date:  1983-01       Impact factor: 4.436
  7 in total
  2 in total

Review 1.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

2.  Potential therapeutic hazards due to drug-drug interaction between topically and systemically coadministered medications.

Authors:  Mei-Juan Lan; Quan Zhou
Journal:  Ther Clin Risk Manag       Date:  2013-07-30       Impact factor: 2.423
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.